Atracurium compared with suxamethonium for outpatient laparoscopy

Area of Science:

• Anesthesiology
• Surgical Procedures

Background:

• Neuromuscular blocking agents are essential for surgical procedures requiring muscle relaxation.
• Outpatient laparoscopy necessitates careful selection of anesthetic agents for rapid recovery and suitability for ambulatory settings.

Purpose of the Study:

• To compare the efficacy and suitability of intravenous atracurium and suxamethonium for outpatient laparoscopy.
• To identify potential advantages of each neuromuscular blocking agent in the context of ambulatory surgery.

Main Methods:

• A randomized study involving thirty patients undergoing outpatient laparoscopy.
• Patients were assigned to receive either intravenous atracurium (0.3 mg/kg) or suxamethonium (1.6 mg/kg) plus infusion.
• Assessment of suitability for outpatient procedures was the primary outcome.

Main Results:

• Both atracurium and suxamethonium were found to be suitable for outpatient laparoscopy.
• No specific adverse events or complications were detailed in relation to suitability.

Conclusions:

• Intravenous atracurium and suxamethonium are both viable options for neuromuscular blockade in outpatient laparoscopy.
• Atracurium may offer specific benefits if the surgical procedure is anticipated to convert from laparoscopy to laparotomy.